| +0.62 / +1.57%|
The 11 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 44.00, with a high estimate of 53.00 and a low estimate of 24.00. The median estimate represents a +9.62% increase from the last price of 40.14.
The current consensus among 14 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.